Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 Nanotech Investing
Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model Technology Investing News
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer Nanotech Investing
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development Technology Investing News
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Nanotech Investing
